Filing Details
- Accession Number:
- 0001236030-25-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-29 07:56:00
- Reporting Period:
- 2025-07-25
- Filing Date:
- 2025-07-29
- Accepted Time:
- 2025-07-29 07:56:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
725363 | Cel Sci Corp | CVM | Biological Products, (No Disgnostic Substances) (2836) | 840916344 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1511858 | Eugene Robert Watson | 245 N. Highland Ave Ne Suite 230-296 Atlanta GA 30307 | Yes | No | No | No |
Transaction Summary
Purchased: | 2,919 shares | Avg. Price: $6.85 | Total Value: $19,995.15 |
Number of Shares After Transactions: | 3,733 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-25 | 2,919 | $6.85 | 3,733 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On July 25, 2025, Mr. Watson purchased 2,919 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available.